NCT05316116 2026-02-05Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)H. Lee Moffitt Cancer Center and Research InstitutePhase EARLY_PHASE1 Terminated6 enrolled
NCT04975555 2025-09-22Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell TherapyUniversity of Alabama at BirminghamPhase 2 Active not recruiting30 enrolled